Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 5/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | NPC1 | O15118 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.64 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.64 |
| ▸ | RELA | Q04206 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1573619 | 1.00 | CYP2D6 (0.69) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL1996527 | 1.00 | CYP2D6 (0.69) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL1874710 | 1.00 | CYP2D6 (0.69) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL22145062 | 0.98 | CYP2D6 (0.71) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL7947076 | 0.91 | CYP2D6 (0.81) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL9650447 | 0.89 | CYP2D6 (0.89) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL31621357 | 0.89 | CYP2D6 (0.89) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL31621352 | 0.89 | CYP2D6 (0.89) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL8615461 | 0.86 | CYP2D6 (0.57) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 | |
| SCHEMBL6364384 | 0.86 | CYP2D6 (0.62) | CYP2D6CYP3A4LMNANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1797953-A1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | CYP2D6 981/4885CYP3A4 500/4885LMNA 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.